The month of August saw a total of 68 mergers and acquisitions announced in 13 sectors of the health care industry. The month’s deal volume dropped ever so slightly from July’s tally of 69 deals. The nine sectors of the health care services segment accounted for 35 deals, or 51% of the month’s total, with the four technology sectors contributing the remaining 33 deals.
Among the individual sectors, Medical Devices led the pack with 15 deals, or 22% of August’s M&A activity. It was followed by Biotechnology with seven deals and Pharmaceuticals and Long-Term Care with six deals each. The Physician Medical Group sector posted just one transaction.
Based on prices revealed to date, a total of $4.0 billion was committed to finance the month’s 68 deals, down significantly from the $35.5 billion spent in July. The technology segment accounted for $3,297,275,500 and the services segment for the remaining $658,630,000.
For the second time this year (the first was February), no billion-dollar deals were announced. The largest deal, valued at $736 million, was posted in the Pharmaceutical sector.
Like this article? Click here for a free trial to the Health Care M&A